Altria Group's Strategic Moves and Financial Performance

Core Viewpoint - Altria Group is transitioning towards smoke-free products while maintaining a strong dividend yield and strategic business moves, supported by FDA approvals and acquisitions [1][6]. Financial Performance - Altria reported stable fundamentals with modest growth in earnings per share (EPS) in the fourth quarter, utilizing pricing power to offset volume declines [3]. - The company has a robust dividend yield of nearly 7%, reflecting its commitment to shareholder value through frequent share buybacks and a disciplined approach to leverage [3][4]. Market Position - Altria's market capitalization is approximately $109.79 billion, indicating its significant presence in the tobacco industry [4]. - The stock price is currently $65.40, with a slight increase of 0.01, or about 1.53%, and has a 52-week range of $52.40 to $68.60 [5]. Analyst Ratings - Citigroup maintains a Neutral rating for Altria, raising its price target from $57 to $65, indicating a positive outlook for the stock's future performance [2][6].